At 6 months, the win ratio favored the device over optimal medical therapy, in large part driven by improved quality of life.

Photo Credit: Adapted from Asch FM. Atrial FMR primer: epidemiology, pathophysiology, imaging features, and clinical presentation. Presented at: TCT 2024. Washington, DC. Patients with moderate or ...

CHICAGO -- Champions of tricuspid transcatheter edge-to-edge repair (TEER) were buoyed by 2-year results of the TRILUMINATE trial marking the first report of reduced heart failure (HF) hospitalization ...

HONG KONG, Feb. 9, 2026 /PRNewswire/ -- Peijia Medical Limited (HKEX: 9996) today announced that it has formally submitted the European Union Medical Device Regulation (EU MDR) CE Mark registration ...

Transcatheter edge-to-edge repair (TEER) is associated with lower mortality and heart failure hospitalization rates among elderly patients with atrial functional mitral regurgitation compared to ...

Outcomes were also determined by the degree of residual mitral regurgitation after TEER (residual AFMR). Among patients in whom residual AFMR was mild or less, the risk of death or hospitalization was ...

Tricuspid transcatheter edge-to-edge repair (T-TEER) significantly reduced the severity of secondary tricuspid regurgitation and improved quality of life after 1 year, according to late-breaking ...

Results of the first randomized controlled trial to directly compare two contemporary transcatheter edge-to-edge repair (TEER) devices for degenerative mitral regurgitation (DMR) found that the PASCAL ...

Please provide your email address to receive an email when new articles are posted on . Access to transcatheter edge-to-edge repair for degenerative mitral regurgitation did not impact annualized ...

Meril Life Sciences, a leading global med-tech company, marked a significant milestone with the launch of MyClip, India’s first Transcatheter Edge-To-Edge Repair (TEER) system, on June 14. The ...